Top 10 Healthcare Companies in the US in 2021 by Pipeline Products
Abbott Diagnostics, Boston Scientific Corp, Thermo Fisher Scientific Inc, Siemens Healthcare Diagnostics Inc, and Beckman Coulter Inc are the 5 top healthcare companies in the US in 2021 by pipeline products. In total, the top 10 healthcare companies in the US had pipeline products of 1,029, where Abbott Diagnostics was the highest (270) and Becton Dickinson and Co was the lowest (59). In total, they generated revenue of $90,771 million with an average revenue growth increase of 20.0%. The highest revenue growth was posted by Thermo Fisher Scientific Inc (21.7%), followed by Boston Scientific Corp (20%). They employed a total of 307,600 people in 2021. The United States of America-based Abbott Diagnostics is the leading healthcare company in the US (by pipeline products). The company is a manufacturer of in vitro diagnostic systems and tests. It offers various core laboratory products, molecular point-of-care products, transfusion medicine, professional services, and a diagnostics portfolio. Abbott’s product portfolio includes laboratory systems for automation, molecular diagnostic systems, and point-of-care systems for blood analysis. The company markets its products through Abbott-owned distribution centers, public warehouses, and third-party distributors. Boston Scientific Corp is one of the leading healthcare companies in the US (by pipeline products). The company reported revenues of $11,888 million for the fiscal year ended December 2021 (FY2021), an increase of 19.9% over FY2020. The company is a medical technology company that is involved in the development, manufacturing, and commercialization of devices for a range of interventional medical specialties. As of December 2021, Boston Scientific had over 18,000 patents and 6,000 pending patent applications worldwide and employs 41,000 people. Thermo Fisher Scientific Inc is another leading healthcare company in the US (by pipeline products). The company reported revenues of $39,211 million for the fiscal year ended December 2021 (FY2021), an increase of 21.7% over FY2020, due to increased demand for products related to electron microscopy instruments as well as chromatography and mass spectrometry instruments. The company is a provider of medical equipment, analytical instruments, reagents and consumables, software, and services to tackle complex analytical challenges in research, diagnostics, and clinical laboratories. It employs 130,000 people.